Understanding modern-day vaccines: what you need to know

References

• Delany I, Rappuoli R, De Gregorio E. Vaccines for the 21st century. EMBO Mol Med. 2014;6:708–720.
   PubMed Web of Science ®Google Scholar
• Tognotti E. The eradication of smallpox, a success story for modern medicine and public health: what lessons for the future? J Infect Dev Ctries. 2010;4:264–266.
   PubMed Web of Science ®Google Scholar
• Siegrist C-A. Vaccine immunology. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia, United States: Elsevier/Saunders; 2013. p. 14–32.
   Google Scholar
• Clem AS. Fundamentals of vaccine immunology. J Glob Infect Dis. 2011;3:73–78.
   PubMedGoogle Scholar
• Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis. 2011;43:683–689.
   PubMed Web of Science ®Google Scholar
• Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev. 1993;15:265–302.
   PubMed Web of Science ®Google Scholar
• Orenstein W, Seib K. Mounting a good offense against measles. N Engl J Med. 2014;371:1661–1663.
   PubMed Web of Science ®Google Scholar
• Swamy GK, Heine RP. Vaccinations for pregnant women. Obstet Gynecol. 2015;125:212–226.
   PubMed Web of Science ®Google Scholar
• Paterson P, Meurice F, Stanberry LR, et al. Vaccine hesitancy and healthcare providers. Vaccine. 2016;34:6700–6706.
   PubMed Web of Science ®Google Scholar
• Hajj Hussein I, Chams N, Chams S, et al. Vaccines through centuries: major cornerstones of global health. Front Public Health. 2015;3:269.
   PubMed Web of Science ®Google Scholar
• Pulendran B, Ahmed R. Immunological mechanisms of vaccination. Nat Immunol. 2011;12:509–517.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec. 2011;86:301–316.
   PubMedGoogle Scholar
• Monath TP, Gershman M, Staples JE, et al. Yellow fever vaccine. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia, United States: Elsevier/Saunders; 2013. p. 870–968.
   Google Scholar
• Yun SI, Lee YM. Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother. 2014;10:263–279.
   PubMed Web of Science ®Google Scholar
• Guy B, Briand O, Lang J, et al. Development of the Sanofi Pasteur tetravalent dengue vaccine: one more step forward. Vaccine. 2015;33:7100–7111.
   PubMed Web of Science ®Google Scholar
• Tillieux SL, Halsey WS, Sathe GM, et al. Comparative analysis of the complete nucleotide sequences of measles, mumps, and rubella strain genomes contained in Priorix-Tetra and ProQuad live attenuated combined vaccines. Vaccine. 2009;27:2265–2273.
   PubMed Web of Science ®Google Scholar
• Tillieux SL, Halsey WS, Thomas ES, et al. Complete DNA sequences of two oka strain varicella-zoster virus genomes. J Virol. 2008;82:11023–11044.
   PubMed Web of Science ®Google Scholar
• Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57:1–30. quiz CE2–4.
   PubMedGoogle Scholar
• Sabin AB, Boulger LR. History of Sabin attenuated poliovirus oral live vaccine strains. J Biol Stand. 1973;1:115–118.
   Google Scholar
• World Health Organization. Polio vaccines: WHO position paper – March, 2016. Wkly Epidemiol Rec. 2016;91:145–168.
   PubMedGoogle Scholar
• Esteves K. Safety of oral poliomyelitis vaccine: results of a WHO enquiry. Bull World Health Org. 1988;66:739–746.
   PubMed Web of Science ®Google Scholar
• Doherty M, Buchy P, Standaert B, et al. Vaccine impact: benefits for human health. Vaccine. 2016;34:6707–6714.
   PubMed Web of Science ®Google Scholar
• Vesikari T. Rotavirus vaccination: a concise review. Clin Microbiol Infect. 2012;18(Suppl 5):57–63.
   PubMed Web of Science ®Google Scholar
• Sridhar S, Brokstad KA, Cox RJ. Influenza vaccination strategies: comparing inactivated and live attenuated influenza vaccines. Vaccines (Basel). 2015;3:373–389.
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S. The present and future of tuberculosis vaccinations. Tuberculosis (Edinb). 2015;95:6–13.
   PubMed Web of Science ®Google Scholar
• World Health Organization. BCG vaccine. WHO position paper. Wkly Epidemiol Rec. 2004;79:27–38.
   PubMedGoogle Scholar
• Strugnell R, Zepp F, Cunningham A, et al. Vaccine antigens. In: Garçon N, Stern PL, Cunningham AL, editors. Understanding modern vaccines: perspectives in vaccinology. Vol. 1. Amsterdam: Elsevier; 2011. p. 61–88.
   Google Scholar
• Cunningham AL, Garcon N, Leo O, et al. Vaccine development: from concept to early clinical testing. Vaccine. 2016;34:6655–6664.
   PubMed Web of Science ®Google Scholar
• Edwards KM, Decker MD. Pertussis vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia, United States: Elsevier/Saunders; 2013. p. 447–492.
   Google Scholar
• Rappuoli R, Pizza M, Del Giudice G, et al. Vaccines, new opportunities for a new society. Proc Natl Acad Sci USA. 2014;111:12288–12293.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Pertussis vaccines: WHO position paper – September 2015. Wkly Epidemiol Rec. 2015;90:433–458.
   PubMedGoogle Scholar
• Clark TG, Cassidy-Hanley D. Recombinant subunit vaccines: potentials and constraints. Dev Biol (Basel). 2005;121:153–163.
   PubMedGoogle Scholar
• Soema PC, Kompier R, Amorij JP, et al. Current and next generation influenza vaccines: formulation and production strategies. Eur J Pharm Biopharm. 2015;94:251–263.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec. 2012;87:461–476.
   PubMedGoogle Scholar
• Offit PA, Quarles J, Gerber MA, et al. Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics. 2002;109:124–129.
   PubMed Web of Science ®Google Scholar
• Michel ML, Tiollais P. Hepatitis B vaccines: protective efficacy and therapeutic potential. Pathol Biol (Paris). 2010;58:288–295.
   PubMed Web of Science ®Google Scholar
• Kaslow DC, Biernaux S. RTS,S: toward a first landmark on the Malaria Vaccine Technology Roadmap. Vaccine. 2015;33:7425–7432.
   PubMed Web of Science ®Google Scholar
• Vandoolaeghe P, Schuerman L. The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination. Expert Rev Vaccines. 2016;15:1481–1493.
   PubMed Web of Science ®Google Scholar
• Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372:2087–2096.
   PubMed Web of Science ®Google Scholar
• Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375:1019–1032.
   PubMed Web of Science ®Google Scholar
• Seib KL, Zhao X, Rappuoli R. Developing vaccines in the era of genomics: a decade of reverse vaccinology. Clin Microbiol Infect. 2012;18 Suppl 5:109–116.
   PubMed Web of Science ®Google Scholar
• Vernikos G, Medini D. Bexsero® chronicle. Pathog Glob Health. 2014;108:305–316.
   PubMed Web of Science ®Google Scholar
• Shirley M, Dhillon S. Bivalent rLP2086 Vaccine (Trumenba®): a review in active immunization against invasive Meningococcal Group B disease in individuals aged 10–25 years. BioDrugs. 2015;29:353–361.
   PubMed Web of Science ®Google Scholar
• Moloney PJ. The preparation and testing of diphtheria toxoid (Anatoxine-Ramon). Am J Public Health (NY). 1926;16:1208–1210.
   Google Scholar
• World Health Organization. Tetanus vaccine. WHO position paper. Wkly Epidemiol Rec. 2006;81:198–208.
   PubMedGoogle Scholar
• World Health Organization. Diphtheria vaccines. WHO position paper. Wkly Epidemiol Rec. 2006;81:21–32.
   PubMedGoogle Scholar
• Pichichero ME. Protein carriers of conjugate vaccines: characteristics, development, and clinical trials. Hum Vaccin Immunother. 2013;9:2505–2523.
   PubMed Web of Science ®Google Scholar
• Bröker M, Berti F, Schneider J, et al. Polysaccharide conjugate vaccine protein carriers as a “neglected valency” – potential and limitations. Vaccine. 2017;35:3286–3294.
   PubMed Web of Science ®Google Scholar
• Borba RC, Vidal VM, Moreira LO. The re-emergency and persistence of vaccine preventable diseases. An Acad Bras Cienc. 2015;87:1311–1322.
   PubMed Web of Science ®Google Scholar
• Roldao A, Mellado MC, Castilho LR, et al. Virus-like particles in vaccine development. Expert Rev Vaccines. 2010;9:1149–1176.
   PubMed Web of Science ®Google Scholar
• Hutter J, Lepenies B. Carbohydrate-based vaccines: an overview. Methods Mol Biol. 2015;1331:1–10.
   PubMedGoogle Scholar
• Poolman J, Borrow R. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines. 2011;10:307–322.
   PubMed Web of Science ®Google Scholar
• Kim JS, Laskowich ER, Arumugham RG, et al. Determination of saccharide content in pneumococcal polysaccharides and conjugate vaccines by GC-MSD. Anal Biochem. 2005;347:262–274.
   PubMed Web of Science ®Google Scholar
• Poolman J, Frasch C, Nurkka A, et al. Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines. Clin Vaccine Immunol. 2011;18:327–336.
   PubMed Web of Science ®Google Scholar
• Pasquale AD, Preiss S, Silva FT, et al. Vaccine adjuvants: from 1920 to 2015 and beyond. Vaccines (Basel). 2015;3:320–343.
   PubMed Web of Science ®Google Scholar
• Wen Y, Shi Y. Alum: an old dog with new tricks. Emerg Microbes Infect. 2016;5:e25.
   PubMed Web of Science ®Google Scholar
• Moser C, Muller M, Kaeser MD, et al. Influenza virosomes as vaccine adjuvant and carrier system. Expert Rev Vaccines. 2013;12:779–791.
   PubMed Web of Science ®Google Scholar
• Garcon N, Di Pasquale A. From discovery to licensure, the adjuvant system story. Hum Vaccin Immunother. 2017;13:19–33.
   PubMed Web of Science ®Google Scholar
• Ramezanpour B, Haan I, Osterhaus A, et al. Vector-based genetically modified vaccines: exploiting Jenner's legacy. Vaccine. 2016;34:6436–6448.
   PubMed Web of Science ®Google Scholar
• Khan KH. DNA vaccines: roles against diseases. Germs. 2013;3:26–35.
   PubMedGoogle Scholar
• Deering RP, Kommareddy S, Ulmer JB, et al. Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines. Expert Opin Drug Deliv. 2014;11:885–899.
   PubMed Web of Science ®Google Scholar
• Stanberry LR, Strugnell R. Vaccines of the future. In: Garçon N, Stern PL, Cunningham AL, editors. Understanding modern vaccines: perspectives in vaccinology. Vol. 1. Amsterdam: Elsevier; 2011. p. 151–199.
   Google Scholar
• Shakya AK, Chowdhury MYE, Tao W, et al. Mucosal vaccine delivery: current state and a pediatric perspective. J Control Release. 2016;240:394–413.
   PubMed Web of Science ®Google Scholar
• Arnou R, Frank M, Hagel T, et al. Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany. Adv Ther. 2011;28:555–565.
   PubMed Web of Science ®Google Scholar
• Sarkanen TO, Alakuijala APE, Dauvilliers YA, et al. Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis. Sleep Med Rev. 2017 [Jun 20]. DOI:10.1016/j.smrv.2017.06.006
   PubMed Web of Science ®Google Scholar
• Kornum BR, Knudsen S, Ollila HM, et al. Narcolepsy. Nat Rev Dis Primers. 2017;3:16100.
   PubMed Web of Science ®Google Scholar
• Lee LY, Garland SM. Human papillomavirus vaccination: the population impact. F1000Res. 2017;6:866.
   PubMedGoogle Scholar
• Ellis RW, Rappuoli R, Ahmed S. Technologies for making new vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia, United States: Elsevier/Saunders; 2013. p. 1182–1199.
   Google Scholar
• Hemming M, Vesikari T. Detection of rotateq vaccine-derived, double-reassortant rotavirus in a 7-year-old child with acute gastroenteritis. Pediatr Infect Dis J. 2014;33:655–656.
   PubMed Web of Science ®Google Scholar